Your browser doesn't support javascript.
loading
Hyperuricaemia and development of type 2 diabetes mellitus in Asian population.
Choi, Byoung Geol; Kim, Dae Jin; Baek, Man Jong; Ryu, Yang Gi; Kim, Suhng Wook; Lee, Min Woo; Park, Ji Young; Noh, Yung-Kyun; Choi, Se Yeon; Byun, Jae Kyeong; Shim, Min Suk; Mashaly, Ahmed; Li, Hu; Park, Yoonjee; Jang, Won Young; Kim, Woohyeun; Kang, Jun Hyuk; Choi, Jah Yeon; Park, Eun Jin; Park, Sung-Hun; Lee, Sunki; Na, Jin Oh; Choi, Cheol Ung; Kim, Eung Ju; Park, Chang Gyu; Seo, Hong Seog; Oh, Dong Joo; Rha, Seung-Woon.
Afiliación
  • Choi BG; Department of Medicine, Korea University Graduate School, Seoul, Korea.
  • Kim DJ; Department of Integrated Biomedical and Life Sciences, Korea University Graduate School, Seoul, Korea.
  • Baek MJ; Department of Thoracic and Cardiovascular Surgery, Guro Hospital, Seoul, Korea.
  • Ryu YG; Department of Thoracic and Cardiovascular Surgery, Guro Hospital, Seoul, Korea.
  • Kim SW; Department of Integrated Biomedical and Life Sciences, Korea University Graduate School, Seoul, Korea.
  • Lee MW; Department of Integrated Biomedical and Life Sciences, Korea University Graduate School, Seoul, Korea.
  • Park JY; Division of Cardiology, Nown Eulji Hospital, Eulji University, Seoul, Korea.
  • Noh YK; School of Mechanical & Aerospace Engineering, Seoul National University, Seoul, Korea.
  • Choi SY; Department of Medicine, Korea University Graduate School, Seoul, Korea.
  • Byun JK; Department of Medicine, Korea University Graduate School, Seoul, Korea.
  • Shim MS; Cardiovascular Center, Korea University Guro Hospital, Seoul, Korea.
  • Mashaly A; Cardiovascular Center, Korea University Guro Hospital, Seoul, Korea.
  • Li H; Department of Medicine, Korea University Graduate School, Seoul, Korea.
  • Park Y; Cardiovascular Center, Korea University Guro Hospital, Seoul, Korea.
  • Jang WY; Cardiovascular Center, Korea University Guro Hospital, Seoul, Korea.
  • Kim W; Cardiovascular Center, Korea University Guro Hospital, Seoul, Korea.
  • Kang JH; Cardiovascular Center, Korea University Guro Hospital, Seoul, Korea.
  • Choi JY; Cardiovascular Center, Korea University Guro Hospital, Seoul, Korea.
  • Park EJ; Cardiovascular Center, Korea University Guro Hospital, Seoul, Korea.
  • Park SH; Cardiovascular Center, Korea University Guro Hospital, Seoul, Korea.
  • Lee S; Cardiovascular Center, Korea University Guro Hospital, Seoul, Korea.
  • Na JO; Cardiovascular Center, Korea University Guro Hospital, Seoul, Korea.
  • Choi CU; Cardiovascular Center, Korea University Guro Hospital, Seoul, Korea.
  • Kim EJ; Cardiovascular Center, Korea University Guro Hospital, Seoul, Korea.
  • Park CG; Cardiovascular Center, Korea University Guro Hospital, Seoul, Korea.
  • Seo HS; Cardiovascular Center, Korea University Guro Hospital, Seoul, Korea.
  • Oh DJ; Cardiovascular Center, Korea University Guro Hospital, Seoul, Korea.
  • Rha SW; Cardiovascular Center, Korea University Guro Hospital, Seoul, Korea.
Clin Exp Pharmacol Physiol ; 45(6): 499-506, 2018 06.
Article en En | MEDLINE | ID: mdl-29266345
ABSTRACT
Recently, meta-analysis studies reported that hyperuricaemia is associated with higher incidence of type 2 diabetes mellitus (T2DM), however, there are limited data on the Asian population. The aim of this observational study is to estimate the long-term impact of hyperuricaemia on the new-onset T2DM and cardiovascular events. This study is based on a single-centre, all-comers, and large retrospective cohort. Subjects that visited from January 2004 to February 2014 were enrolled using the electronic database of Korea University Guro Hospital. A total of 10 505 patients without a history of T2DM were analyzed for uric acid, fasting glucose and haemoglobin (Hb) A1c level. Inclusion criteria included both Hb A1c <5.7% and fasting glucose level <100 mg/dL without T2DM. Hyperuricaemia was defined as a uric acid level ≥7.0 mg/dL in men, and ≥6.5 mg/dL in women. To adjust baseline confounders, a propensity score matching (PSM) analysis was performed. The impact of hyperuricaemia on the new-onset T2DM and cardiovascular events were compared with the non-hyperuricaemia during the 5-year clinical follow-up. After PSM, baseline characteristics of both groups were balanced. In a 5-year follow-up, the hyperuricaemia itself was a strong independent predictor of the incidence of new-onset T2DM (HR, 1.78; 95% CI, 1.12 to 2.8). Hyperuricaemia was a strong independent predictor of new-onset T2DM, which suggests a substantial implication for a correlation between uric acid concentration and insulin resistance (or insulin sensitivity). Also, hyperuricaemia is substantially implicated in cardiovascular risks and the further long-term cardiovascular events in the crude population, but it is not an independent predictor of long-term cardiovascular mortality in the matched population.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Hiperuricemia / Pueblo Asiatico / Diabetes Mellitus Tipo 2 Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Exp Pharmacol Physiol Año: 2018 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Hiperuricemia / Pueblo Asiatico / Diabetes Mellitus Tipo 2 Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Exp Pharmacol Physiol Año: 2018 Tipo del documento: Article